Levaquin (levofloxacin) has been approved by the FDA for the treatment and prevention of the plague. Levofloxacin is a synthetic antibiotic of the fluoroquinolones drug class; it is currently used for the treatment of severe bacterial infection, or infections for which other antibiotics have not worked. Levaquin is produced and marketed by Janssen Pharmaceuticals Inc., a Johnson & Johnson company.
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome. "This approval offers another treatment option for... Read Post
The U.S. Food and Drug Administration approved the first generic versions of Levaquin (levofloxacin), an antibiotic approved to treat certain infections in people ages 18 and older. Levofloxacin is used to treat mild, moderate, or s... Read Post